Advertisement
Advertisement
U.S. Markets open in 5 hrs 5 mins
Advertisement
Advertisement
Advertisement
Advertisement

Cabaletta Bio, Inc. (CABA)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
0.6311+0.0019 (+0.30%)
At close: 04:00PM EDT
0.6880 +0.06 (+9.02%)
After hours: 05:17PM EDT
Advertisement

Yahoo Finance will soon be upgrading our Conversations message board platform to provide a better experience for our users. Only comments published since April 21, 2021 will be visible on Yahoo Finance after the upgrade. If you wish to download and save any of your older comments, please submit a request via the Privacy Dashboard by no later than Sept. 30.

Sign in to post a message.
  • P
    PJ
    This new data presented by CABA is very positive and keeps the drug on track in a strong way through the trials. I expect this share price to respond favorably this week.
  • d
    dr_eeeee
    Congratulations? a new all time low! Sell this #$%$ company and distribute the cash back to the bag holders.
  • b
    bioimmunomabman
    Hey management, less talking, more doing and start cutting costs. This company can't afford 60+ employees. Stop wasting the shareholders $. Either 1) find a buyer, 2)cut, expenses big time or 3) return the cash to the shareholders while you still have some!
  • h
    hai
    Will see $1.6 tomorrow
  • f
    full risc
    oversold ,,,,,,,,,more than 3$ cash a share
  • C
    Chris
    Data leak ahead of the September conference?
  • b
    bioimmunomabman
    nice day so far. Any news?
  • G
    God
    In a report released yesterday, Uy Ear from Mizuho Securities maintained a Buy rating on Cabaletta Bio, with a price target of $10.00. The company’s shares closed last Friday at $0.94.
  • h
    harry
    Big sell-off this afternoon…shorts?
  • G
    God
    Douglas Tsao from HC Wainwright came out this morning and reiterated a buy on the stock with a PT of $11.
  • d
    dr_eeeee
    Sell the rumor (MS downgraded)…buy the fact
  • b
    bioimmunomabman
    With the stock trading at about .33 x cash maybe this result with the help of the new large shareholder pushes management to look for a buyer.
  • b
    bioimmunomabman
    CABA had a presentation today. The CEO says he has some levers to pull and they have plenty of cash. I'd like to hear 1) they are cutting costs to the bone to preserve cash and 2) they are open to all options to maximize shareholder value. Hopefully some of the larger shareholders and their BOD are saying the same. CEO needs to take a pay cut.
  • G
    God
    In a report released yesterday, Douglas Tsao from H.C. Wainwright maintained a Buy rating on Cabaletta Bio, with a price target of $11.00.
  • G
    Gary b
    This must be a short attack
  • h
    harry
    Maybe back down to $1.20-1.30 by weeks end based on market sentiment from last week
  • h
    harry
    Why did this bounce today?? 34mil shares, absurd!! Probably shorts will take their profits tomorrow
  • G
    God
    5x normal volume today. One and a half million shares traded/bought.
  • V
    Vicki
    $3 at the close !!!!! BUY BUY BUY
    Bullish
  • A
    Adam
    gees it's heading to zero fast
Advertisement
Advertisement